FDA approves NDA labeling supplement allowing re-administration of iDose TR | Optometry Times - Clinical News
Published on January 28, 2026
Glaukos noted under the updated labeling, physicians may now re-administer iDose TR more than once in patients who maintain a healthy cornea, as defined by corneal endothelial cell density parameters.